- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors ; volume:17 ; number:1 ; day:12 ; month:1 ; year:2018 ; pages:1-12 ; date:12.2018
Molecular cancer ; 17, Heft 1 (12.1.2018), 1-12, 12.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Zhang, Erhao
- Contributor
-
Gu, Jieyi
Xu, Hanmei
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0759-3
- URN
-
urn:nbn:de:1111-201803163368
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Erhao
- Gu, Jieyi
- Xu, Hanmei
- SpringerLink (Online service)
Other Objects (12)
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapy for multiple myeloma
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapy for multiple myeloma
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapy for multiple myeloma
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric Antigen Receptor T Cell Research For Clinical Applications